Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 24 studies | 31% ± 10% | |
monocyte | 12 studies | 25% ± 8% | |
macrophage | 12 studies | 35% ± 17% | |
neutrophil | 11 studies | 43% ± 13% | |
non-classical monocyte | 10 studies | 20% ± 6% | |
alveolar macrophage | 7 studies | 54% ± 23% | |
myeloid cell | 5 studies | 29% ± 12% | |
conventional dendritic cell | 4 studies | 21% ± 6% | |
dendritic cell | 4 studies | 26% ± 4% | |
intermediate monocyte | 3 studies | 38% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 4 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 2423.02 | 578 / 578 | 85% | 24.90 | 987 / 1155 |
spleen | 100% | 846.57 | 241 / 241 | 0% | 0 | 0 / 0 |
thymus | 32% | 43.28 | 207 / 653 | 63% | 6.57 | 382 / 605 |
pancreas | 8% | 10.62 | 25 / 328 | 79% | 7.23 | 140 / 178 |
peripheral blood | 85% | 10811.51 | 793 / 929 | 0% | 0 | 0 / 0 |
breast | 34% | 53.14 | 155 / 459 | 42% | 2.30 | 472 / 1118 |
adipose | 72% | 247.49 | 868 / 1204 | 0% | 0 | 0 / 0 |
intestine | 23% | 38.34 | 223 / 966 | 46% | 3.27 | 243 / 527 |
stomach | 21% | 45.25 | 76 / 359 | 48% | 3.12 | 136 / 286 |
kidney | 36% | 52.96 | 32 / 89 | 32% | 2.52 | 284 / 901 |
bladder | 14% | 149.33 | 3 / 21 | 50% | 7.95 | 254 / 504 |
ovary | 17% | 20.66 | 31 / 180 | 45% | 2.14 | 195 / 430 |
esophagus | 12% | 21.22 | 172 / 1445 | 48% | 3.53 | 88 / 183 |
blood vessel | 60% | 183.87 | 796 / 1335 | 0% | 0 | 0 / 0 |
uterus | 21% | 39.01 | 35 / 170 | 39% | 3.17 | 178 / 459 |
heart | 51% | 134.06 | 439 / 861 | 0% | 0 | 0 / 0 |
liver | 38% | 65.83 | 85 / 226 | 10% | 0.72 | 40 / 406 |
brain | 11% | 16.92 | 289 / 2642 | 31% | 3.99 | 220 / 705 |
skin | 6% | 13.18 | 113 / 1809 | 32% | 4.64 | 151 / 472 |
lymph node | 0% | 0 | 0 / 0 | 38% | 8.53 | 11 / 29 |
tonsil | 0% | 0 | 0 / 0 | 38% | 1.86 | 17 / 45 |
prostate | 26% | 44.58 | 63 / 245 | 2% | 0.07 | 11 / 502 |
adrenal gland | 11% | 12.07 | 28 / 258 | 10% | 1.39 | 22 / 230 |
muscle | 6% | 6.84 | 50 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002250 | Biological process | adaptive immune response |
GO_0070945 | Biological process | neutrophil-mediated killing of gram-negative bacterium |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_0002367 | Biological process | cytokine production involved in immune response |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0032602 | Biological process | chemokine production |
GO_0045087 | Biological process | innate immune response |
GO_0006959 | Biological process | humoral immune response |
GO_0009986 | Cellular component | cell surface |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0038023 | Molecular function | signaling receptor activity |
Gene name | TREM1 |
Protein name | Triggering receptor expressed on myeloid cells 1 (TREM-1) (Triggering receptor expressed on monocytes 1) (CD antigen CD354) Triggering receptor expressed on myeloid cells 1 |
Synonyms | hCG_32869 |
Description | FUNCTION: [Isoform 1]: Cell surface receptor that plays important roles in innate and adaptive immunity by amplifying inflammatory responses . Upon activation by various ligands such as PGLYRP1, HMGB1 or HSP70, multimerizes and forms a complex with transmembrane adapter TYROBP/DAP12 . In turn, initiates a SYK-mediated cascade of tyrosine phosphorylation, activating multiple downstream mediators such as BTK, MAPK1, MAPK3 or phospholipase C-gamma . This cascade promotes the neutrophil- and macrophage-mediated release of pro-inflammatory cytokines and/or chemokines, as well as their migration and thereby amplifies inflammatory responses that are triggered by bacterial and fungal infections . By also promoting the amplification of inflammatory signals that are initially triggered by Toll-like receptor (TLR) and NOD-like receptor engagement, plays a major role in the pathophysiology of acute and chronic inflammatory diseases of different etiologies including septic shock and atherosclerosis . .; FUNCTION: [Isoform 2]: Acts as a decoy receptor, counterbalancing TREM1 pro-inflammatory activity through the neutralization of its lignad. . |
Accessions | ENST00000334475.10 [Q9NP99-2] ENST00000244709.9 [Q9NP99-1] ENST00000589614.5 Q38L15 K7EKM5 ENST00000591620.1 [Q9NP99-3] Q9NP99 |